4 assets in Testicular Embryonal Carcinoma

Therapeutic assets addressing Testicular Embryonal Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Testicular Embryonal Carcinoma	Children's Oncology Group	P3	BB (66)
Bleomycin Testicular Embryonal Carcinoma	Children's Oncology Group	P3	BB (64)
Cis-Diamminedichloroplatinum Ii Testicular Embryonal Carcinoma	Children's Oncology Group	P3	BB (64)
Etoposide Testicular Embryonal Carcinoma	Children's Oncology Group	P3	BB (64)